Login / Signup

Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients.

Stephen K KyeiHenry OgbomoShuShun LiMartina Timm-McCannRichard F XiangShaunna M HustonAnutosh GangulyPina ColarussoM John GillChristopher H Mody
Published in: mBio (2016)
The mechanisms by which NK cells bind directly to pathogens and deploy their deadly cytolytic machinery during microbial host defense are only beginning to be elucidated. With the goal of understanding this process, we used NK cells from HIV-infected patients, which were known to have a defect in killing of Cryptococcus neoformans Taking advantage of previous studies that had shown that IL-12 restored killing, we used the cytokine as a gain-of-function approach to define the relevance of multiple steps in the recognition and cytolytic pathway. We demonstrated that NK cells from HIV-infected patients failed to kill Cryptococcus due to defects in perforin expression, granule polarization, and release of perforin. Additionally, IL-12 restored recognition of C. neoformans through binding of the NK-activating receptor NKp30. These observations identify important mechanisms used by NK cells to kill microbes and determine that defects in NK cells from HIV-infected patients are reversible.
Keyphrases
  • nk cells
  • hiv infected patients
  • antiretroviral therapy
  • binding protein
  • poor prognosis
  • signaling pathway
  • gram negative
  • transcription factor
  • dna binding
  • multidrug resistant